Logo - springer
Slogan - springer

Springer Healthcare | Dermatology and Therapy

Dermatology and Therapy

Dermatology and Therapy

Research, treatment and aesthetic interventions in dermatology

Co-Editors-in-Chief: Alan Menter
Co-Editor-in-Chief: Richard Warren

ISSN: 2193-8210 (print version)
ISSN: 2190-9172 (electronic version)

Journal no. 13555

Learn more about the metrics of this journal Springer Open Access Journal

Aims and Scope

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

Rapid Publication

The journals publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3-4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, while still providing robust peer review. Combined with the journal's open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of dermatologic therapies.

Personal Service

The journal's dedicated in-house editorial team offer a personal 'concierge service' meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure the articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.

Enhanced Digital Features

Moving forward from traditional publishing, Dermatology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. All these enhanced features are open access and are peer reviewed to the same high standard as the article itself. By having a choice of media not limited to text, figres and tables alone, readers may receive information more effectively, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research. For questions relating to enhanced features please contact adisdigitalfeatures@springer.com.

Plain Language Summaries

Articles published in Dermatology and Therapy may be accompanied by plain language summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. Both the enhanced digital feature and plain language summaries can help to reach a broader audience thus supporting the effective dissemination of research

Publication Fees

Upon acceptance of your article for publication, you will be required to pay the article processing charge of €340/ $380 per typeset page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive double-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

Copyright

Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Contact

For more information about the journal, please contact matthew.evans@springer.com.

Related subjects » Springer Healthcare

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, PubMedCentral, SCOPUS, EMBASE, Google Scholar, Current Contents/Clinical Medicine, DOAJ, EBSCO Academic Search, EBSCO Discovery Service, EBSCO TOC Premier, EMCare, INIS Atomindex, OCLC WorldCat Discovery Service, ProQuest Central, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Pharma Collection, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

    Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published in Dermatology and Therapy may be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances.

    Moving forward from traditional publishing, Dermatology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself. For questions relating to enhanced features please contact adisdigitalfeatures@springer.com.

    Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Upon acceptance of your article for publication, you will be required to pay the article processing charge of €340/ $380 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive double-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

    For more information about the journal, please contact matthew.evans@springer.com.

  • Submit Online
  • Instructions for Authors (pdf, 1.1 MB)
  • Compliance with Ethical Policies
  • Author Disclosure Form (docx, 45 kB)
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    Open Access Dermatology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Dermatology and Therapy.